Search clinical trials for: Remicade (infliximab)

Total 422 results

Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

Crohn's Disease
Biocad

Completed

Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Russian Federation, Belarus
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

Arthritis, Psoriatic
Centocor, Inc.
Centocor BV

Completed

A Long-term Safety Study of Infliximab (Remicade)

Arthritis, Rheumatoid | Psoriasis | Crohn Disease

United States, Canada, France, Germany, Poland, United Kingdom, Belgium, Spain, Argentina, Israel, Switzerland, Finland, Sweden, Netherlands, Austria, Hungary, Ireland, Norway, Denmark
Xiaomin Zhang

Active, not recruiting

A Clinical Trial of Infliximab for Childhood Uveitis

Uveitis | Infliximab
Egla C. Rabinovich
Childhood Arthritis and Rheumatology Research Alliance

Completed

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Chronic Uveitis

United States
Peking Union Medical College Hospital
Changhai Hospital; West China Hospital; Shenzhen People's Hospital; First People... and other collaborators

Unknown

Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis (ULTRA)

Rheumatoid Arthritis | Ultrasonography | Infliximab

China
Center for Integrated Rehabilitation and Organ...
Centocor, Inc.

Completed

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

Cachexia | COPD

Netherlands
Merck Sharp & Dohme LLC

Completed

Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)

Arthritis, Rheumatoid
James Chodosh, MD, MPH
Massachusetts Eye and Ear Infirmary; Fonds de recherche en ophtalmologie de...

Withdrawn

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Stevens-Johnson Syndrome | Mucous Membrane Pemphigoid | Toxic Epidermal Necrolysis (Lyell) Syndrome

United States, Canada
Gu Jieruo

Completed

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Spondylitis

China
Oregon Health and Science University
Centocor, Inc.

Completed

A Clinical Trial of Infliximab for Uveitis

Uveitis
Pfizer

Completed

A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)

Healthy

United States
Diakonhjemmet Hospital
South-Eastern Norway Regional Health Authority

Completed

The NOR-SWITCH Study (NOR-SWITCH)

Rheumatoid Arthritis | Crohn's Disease | Ulcerative Colitis | Psoriatic Arthritis | Spondyloarthritis | Psoriasis Chronic

Norway
Centre hospitalier de l'Université de Montréal...
Ottawa Hospital Research Institute; Maisonneuve-Rosemont Hospital; Niagara Health... and other collaborators

Recruiting

Topical Infliximab in Eyes With Penetrating Keratoplasty

Glaucoma Following Surgery

Canada
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects

Healthy

Germany
Hospital General de Mexico
Schering-Plough

Completed

Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies

Spondylarthropathies

Mexico
Loyola University

Withdrawn

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Toxic Epidermal Necrolysis
Merck Sharp & Dohme LLC

Terminated

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Psoriasis
University of Pittsburgh
Centocor, Inc.

Completed

Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery

Crohn's Disease

United States
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

European Safety Registry in Ulcerative Colitis (P04808) (OPUS)

Ulcerative Colitis
Merck Sharp & Dohme LLC

Completed

Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352) (CANDLE)

Spondylitis, Ankylosing
Icahn School of Medicine at Mount Sinai

Withdrawn

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema

Uveitic Macular Edema | Intraocular Inflammation

United States
Epirus Biopharmaceuticals (Switzerland) GmbH

Unknown

BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study

Rheumatoid Arthritis
Samsung Bioepis Co., Ltd.

Completed

A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Bulgaria, Lithuania
Biocad

Completed

Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Russian Federation
HaEmek Medical Center, Israel
Bnai Zion Medical Center; Carmel Medical Center

Withdrawn

Intraarticular Injection of Infliximab

Arthritis

Israel
Pfizer

Completed

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Rheumatoid Arthritis

Jordan, Korea, Republic of, United States, Poland, Japan, Hungary, South Africa, Ukraine, Germany, Israel, Philippines, Serbia, Australia, Georgia, Czechia, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Guatemala, Lithuania, M... and more
University of Athens

Terminated

Treatment of Refractory Diabetic Macular Edema With Infliximab

Diabetic Retinopathy | Diabetic Macular Edema | Visual Acuity

Greece
Janssen Scientific Affairs, LLC

Terminated

An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease (ADAPT)

Inflammatory Bowel Diseases

United States, Canada
Children's Hospital Medical Center, Cincinnati
Crohn's and Colitis Foundation

Completed

Anti-TNF Therapy for Refractory Colitis in Hospitalized Children (ARCH)

Colitis, Ulcerative | Bowel Diseases, Inflammatory

United States, Canada
University Hospitals Cleveland Medical Center
Centocor, Inc.

Completed

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease | Pyoderma Gangrenosum

United States
Massachusetts Eye and Ear Infirmary

Withdrawn

Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

Stevens-Johnson Syndrome | Corneal Blindness

United States
Samsung Medical Center

Completed

Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy

Crohn's Disease

Korea, Republic of
Swiss EE Study Group

Completed

Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis (IEE)

Esophagitis

Switzerland
Chinese University of Hong Kong

Completed

Combination Methotrexate and Infliximab

Ankylosing Spondylitis
Icahn School of Medicine at Mount Sinai

Unknown

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema

Diabetic Macular Edema

United States
Copenhagen University Hospital at Herlev

Completed

Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission (STOP IT)

Crohn Disease

Sweden, Denmark, Finland, Norway
Grupo de Estudo da Doença Inflamatória Intestinal

Completed

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis (HERICA)

Ulcerative Colitis

Portugal
Centre hospitalier de l'Université de Montréal...
Fonds de recherche en ophtalmologie de l'Université de Montréal

Recruiting

Topical Infliximab for Sterile Corneal Melt

Sterile Corneal Melt

Canada
University of California, San Francisco

Completed

Early Serum Infliximab Levels in Severe Ulcerative Colitis. (EaSiFx)

Inflammatory Bowel Disease | Ulcerative Colitis (UC)

United States
University of Alberta
The Hospital for Sick Children; Children's Hospital of Eastern Ontario; Alberta... and other collaborators

Completed

IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study (IDeaL)

Crohn's Disease | Inflammatory Bowel Disease

Canada
Celltrion

Completed

Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

Rheumatoid Arthritis

Korea, Republic of
Hospital Universitario Marqués de Valdecilla
Schering-Plough

Unknown

Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica

Polymyalgia Rheumatica

Spain
Merck Sharp & Dohme LLC

Terminated

Treatment With Infliximab in a Medical Setting (Study P05587) (OPTIMIST)

Crohn's Disease
Ain Shams University
Misr International University

Completed

Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome

Covid19 | Corona Virus Infection | Cytokine Storm

Egypt
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC

Completed

Assessment of Long-Term Infliximab for Psoriasis (P05319) (REALITY)

Psoriasis
Merck Sharp & Dohme LLC

Completed

Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Terminated

Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

Crohn Disease

Search clinical trials for: Remicade (infliximab)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations